• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于艾滋病毒/艾滋病事件发生时间数据分析的竞争风险多状态模型:埃塞俄比亚全国回顾性队列数据集

Competing risks multi-state model for time-to-event data analysis of HIV/AIDS: a retrospective cohort national datasets, Ethiopia.

作者信息

Kumssa Tsegaye H, Mulu Andargachew, Mihret Adane, Asfaw Zeytu G

机构信息

Department of Statistics, Hawassa University, Hawassa, Ethiopia.

Armauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia.

出版信息

BMC Infect Dis. 2024 Dec 18;24(1):1412. doi: 10.1186/s12879-024-10280-9.

DOI:10.1186/s12879-024-10280-9
PMID:39695972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11654082/
Abstract

INTRODUCTION

Tuberculosis (TB) remains the most common opportunistic infection and leading cause of death among individuals living with HIV/AIDS in Ethiopia. Its significant impact on morbidity and mortality underscores the crucial link between these two diseases. While the advent of antiretroviral therapy (ART) has led to a dramatic decline in mortality rates among HIV/AIDS patients, TB continues to pose a substantial threat. This study aims to estimate the probability of death due to TB among HIV/AIDS patients on ART, considering the presence of various competing risks, including diarrhea, other infections, and unknown/unspecified causes. Also we have assessed the effects of prognostic factors on HIV/AIDS cause specific deaths, compared with the death from other competing risks, and exploring leading cause of death among HIV/AIDS patients on Antiretroviral Therapy.

METHODS

Data from a retrospective research examining the effectiveness of antiretroviral therapy (ART) in Ethiopia were used in this investigation. The data came from medical records of patients who were part of the national ART program. A total of 39,590 records were gathered between October 2019 and March 2020 from all regions of Ethiopia as well as the administration cities of Addis Ababa and Dire Dawa. The study facilities were grouped using a multi-stage sample technique and simple random selection was used to select health facility and a person record from medical records. In the presence of the competing causes of death, Cause specific hazard, subdistribution hazard model and flexible parametric proportional hazard model have been used to assess the effect of covariates on the risk of death, with the cmprisk package in R4.3.2 software.

RESULTS

Out of the total 1212 deaths, 542(44.7%) died competing with other opportunistic infection (TE-Esophageal Candidiasis, TO-oral, CT-CNS Toxoplasmosis, CM-Crypotococcal Meningitis…), 421 (34.7%) died due to tuberculosis and the remaining death were unknown/Not specified infection 222(18.3%) and diarrhea 27(2.2%). Rates of mortality caused by tuberculosis, competing with other opportunistic infection, diarrhea and unknown/Not specified were 3.5, 4.5, 0.2 and 1.8 per 1000 person-months, respectively. Having a higher CD4 count at diagnosis, responding to combination antiretroviral treatment (cART) six months after start, and having prophylactic treatment for pneumocystis pneumonia (PCP) decreased the risk of tuberculosis, other opportunistic infections, and unidentified and diarrheal causes of death. However, older age, late HIV.AIDS diagnosis, and the last HIV/AIDS WHO clinical stages increased the hazard of tuberculosis and other opportunistic disease mortality. Additionally, male gender, older age and last HIV clinical stages increased the mortality HIV/AIDS patients.

CONCLUSION

The findings of this study demonstrated that TB, an opportunistic infection, was the primary cause of death in HIV/AIDS patients, despite the presence of several competing risks, such as diarrhea, other infections, and an undetermined or unclear cause. It's important to use effective techniques to quickly detect those who have HIV or AIDS and provide them with care and treatment to increase their chances of surviving.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9559/11654082/0a17509303f1/12879_2024_10280_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9559/11654082/ad62f1078970/12879_2024_10280_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9559/11654082/8c373ea5da2b/12879_2024_10280_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9559/11654082/478af690ac13/12879_2024_10280_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9559/11654082/0a17509303f1/12879_2024_10280_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9559/11654082/ad62f1078970/12879_2024_10280_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9559/11654082/8c373ea5da2b/12879_2024_10280_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9559/11654082/478af690ac13/12879_2024_10280_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9559/11654082/0a17509303f1/12879_2024_10280_Fig4_HTML.jpg
摘要

引言

在埃塞俄比亚,结核病(TB)仍然是艾滋病毒/艾滋病感染者中最常见的机会性感染和主要死因。它对发病率和死亡率的重大影响突出了这两种疾病之间的关键联系。虽然抗逆转录病毒疗法(ART)的出现使艾滋病毒/艾滋病患者的死亡率大幅下降,但结核病仍然构成重大威胁。本研究旨在估计接受抗逆转录病毒治疗的艾滋病毒/艾滋病患者因结核病死亡的概率,同时考虑各种竞争风险的存在,包括腹泻、其他感染以及不明/未指明原因。此外,我们评估了预后因素对艾滋病毒/艾滋病特定病因死亡的影响,并与其他竞争风险导致的死亡进行比较,同时探索接受抗逆转录病毒治疗的艾滋病毒/艾滋病患者的主要死因。

方法

本研究使用了一项回顾性研究的数据,该研究考察了埃塞俄比亚抗逆转录病毒疗法(ART)的有效性。数据来自参与国家抗逆转录病毒治疗项目患者的医疗记录。2019年10月至2020年3月期间,从埃塞俄比亚所有地区以及亚的斯亚贝巴和德雷达瓦行政城市共收集了39590份记录。研究机构采用多阶段抽样技术进行分组,并使用简单随机抽样从医疗记录中选择医疗机构和个人记录。在存在竞争死因的情况下,使用特定病因风险、亚分布风险模型和灵活参数比例风险模型,借助R4.3.2软件中的cmprisk包来评估协变量对死亡风险的影响。

结果

在总共1212例死亡病例中,542例(44.7%)死于与其他机会性感染竞争(TE - 食管念珠菌病、TO - 口腔、CT - 中枢神经系统弓形虫病、CM - 隐球菌性脑膜炎……),421例(34.7%)死于结核病,其余死亡原因不明/未指明感染222例(18.3%),腹泻27例(2.2%)。结核病、与其他机会性感染竞争、腹泻以及不明/未指明原因导致的死亡率分别为每1000人月3.5例、4.5例、0.2例和1.8例。诊断时CD4细胞计数较高、开始联合抗逆转录病毒治疗(cART)六个月后有反应以及接受肺孢子菌肺炎(PCP)预防性治疗可降低结核病、其他机会性感染以及不明和腹泻性死因的风险。然而,年龄较大、艾滋病毒/艾滋病诊断较晚以及世界卫生组织艾滋病毒/艾滋病最后临床阶段增加了结核病和其他机会性疾病死亡的风险。此外,男性、年龄较大以及艾滋病毒最后临床阶段增加了艾滋病毒/艾滋病患者的死亡率。

结论

本研究结果表明,尽管存在腹泻、其他感染以及未确定或不明确原因等多种竞争风险,但机会性感染结核病仍是艾滋病毒/艾滋病患者的主要死因。使用有效技术快速检测出艾滋病毒或艾滋病感染者并为其提供护理和治疗以增加他们的存活机会非常重要。

相似文献

1
Competing risks multi-state model for time-to-event data analysis of HIV/AIDS: a retrospective cohort national datasets, Ethiopia.用于艾滋病毒/艾滋病事件发生时间数据分析的竞争风险多状态模型:埃塞俄比亚全国回顾性队列数据集
BMC Infect Dis. 2024 Dec 18;24(1):1412. doi: 10.1186/s12879-024-10280-9.
2
Multi-state Markov model for time to treatment changes for HIV/AIDS patients: a retrospective cohort national datasets, Ethiopia.用于 HIV/AIDS 患者治疗时间变化的多状态马尔可夫模型:埃塞俄比亚的回顾性队列国家数据集。
BMC Infect Dis. 2024 Jun 24;24(1):627. doi: 10.1186/s12879-024-09469-9.
3
Incidence and predictors of reoccurrence of opportunistic infection among adult HIV/AIDS patients attending ART clinic at public health facilities in Arba Minch town, southern Ethiopia: A retrospective cohort study.在埃塞俄比亚南部 Arba Minch 镇公共卫生设施接受抗逆转录病毒疗法 (ART) 诊所治疗的成年艾滋病毒/艾滋病患者中,机会性感染再发的发生率和预测因素:一项回顾性队列研究。
PLoS One. 2021 Dec 31;16(12):e0261454. doi: 10.1371/journal.pone.0261454. eCollection 2021.
4
Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.异烟肼预防性治疗对降低埃塞俄比亚亚的斯亚贝巴公共卫生设施中艾滋病毒/艾滋病感染者活动性结核病发病率的有效性:一项历史性队列研究。
BMC Infect Dis. 2017 Jan 3;17(1):5. doi: 10.1186/s12879-016-2109-7.
5
Time to death and its predictors among HIV patients on antiretroviral therapy in public health facilities of Horro Guduru Wallaga zone, Ethiopia: a retrospective cohort study.埃塞俄比亚霍罗古杜鲁瓦拉加地区公共卫生设施中接受抗逆转录病毒治疗的艾滋病毒患者的死亡时间及其预测因素:一项回顾性队列研究
Front Public Health. 2025 Apr 16;13:1565573. doi: 10.3389/fpubh.2025.1565573. eCollection 2025.
6
Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil - associated factors and causes of death.巴西里约热内卢HIV-1与结核病合并感染患者的死亡率——相关因素及死因
BMC Infect Dis. 2017 May 30;17(1):373. doi: 10.1186/s12879-017-2473-y.
7
Incidence of common opportunistic infections among HIV-infected children on ART at Debre Markos referral hospital, Northwest Ethiopia: a retrospective cohort study.在德布雷马克罗斯转诊医院,接受抗逆转录病毒疗法的艾滋病毒感染儿童常见机会性感染的发生率:一项回顾性队列研究。
BMC Infect Dis. 2020 Jan 16;20(1):50. doi: 10.1186/s12879-020-4772-y.
8
Incidence of death and its predictors among TB/HIV coinfected adult patients receiving anti-retroviral therapy at Gambelia referral hospital, Southwest Ethiopia, 2022.2022年埃塞俄比亚西南部甘贝利阿转诊医院接受抗逆转录病毒治疗的结核病/艾滋病合并感染成年患者的死亡发生率及其预测因素
BMC Infect Dis. 2025 Apr 10;25(1):500. doi: 10.1186/s12879-025-10878-7.
9
Opportunistic infections among people living with HIV/AIDS attending antiretroviral therapy clinics in Gedeo Zone, Southern Ethiopia.艾滋病毒/艾滋病患者在埃塞俄比亚南部盖多地区接受抗逆转录病毒治疗诊所中出现的机会性感染。
BMC Res Notes. 2024 Aug 15;17(1):225. doi: 10.1186/s13104-024-06888-4.
10
Magnitude of opportunistic diseases and their predictors among adult people living with HIV enrolled in care: national level cross sectional study, Ethiopia.成人艾滋病毒感染者中机会性疾病及其预测因素的严重程度:全国层面的横断面研究,埃塞俄比亚。
BMC Public Health. 2018 Jul 3;18(1):820. doi: 10.1186/s12889-018-5733-x.

本文引用的文献

1
Determinants of Loss to Follow Up Among Adult People Living with HIV Enrolled in Antiretroviral Therapy in West Wollega Public Hospitals, Oromia, Ethiopia.埃塞俄米亚奥罗米亚州西沃莱加公立医院接受抗逆转录病毒治疗的成年艾滋病毒感染者失访的决定因素
HIV AIDS (Auckl). 2024 Feb 26;16:59-71. doi: 10.2147/HIV.S426196. eCollection 2024.
2
MSMpred: interactive modelling and prediction of individual evolution via multistate models.MSMpred:通过多状态模型进行个体进化的交互式建模和预测。
BMC Med Res Methodol. 2023 May 24;23(1):126. doi: 10.1186/s12874-023-01951-3.
3
Methods to Analyze Time-to-Event Data: The Cox Regression Analysis.
分析事件时间数据的方法:Cox 回归分析。
Oxid Med Cell Longev. 2021 Nov 30;2021:1302811. doi: 10.1155/2021/1302811. eCollection 2021.
4
A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.南非北部农村诊所接受抗逆转录病毒疗法的结核合并 HIV 感染者中病毒学失败对 HIV/AIDS 进展影响的马尔可夫模型。
S Afr Med J. 2020 Mar 30;110(4):313-319. doi: 10.7196/SAMJ.2020.v110i4.13934.
5
Determinants of AIDS and non-AIDS related mortality among people living with HIV in Shiraz, southern Iran: a 20-year retrospective follow-up study.伊朗南部设拉子地区艾滋病毒感染者的艾滋病和非艾滋病相关死亡率的决定因素:一项为期 20 年的回顾性随访研究。
BMC Infect Dis. 2019 Dec 30;19(1):1094. doi: 10.1186/s12879-019-4676-x.
6
Trends in mortality among ART-treated HIV-infected adults in the Asia-Pacific region between 1999 and 2017: results from the TREAT Asia HIV Observational Database (TAHOD) and Australian HIV Observational Database (AHOD) of IeDEA Asia-Pacific.1999 年至 2017 年亚太地区接受抗逆转录病毒疗法治疗的艾滋病毒感染者的死亡率趋势:来自 TREAT Asia HIV 观察性数据库(TAHOD)和 IeDEA 亚太澳大利亚艾滋病毒观察数据库(AHOD)的结果。
J Int AIDS Soc. 2019 Jan;22(1):e25219. doi: 10.1002/jia2.25219.
7
Factors Associated with Mortality of TB/HIV Co-infected Patients in Ethiopia.埃塞俄比亚结核病/艾滋病合并感染患者死亡率的相关因素
Ethiop J Health Sci. 2017 Feb;27(Suppl 1):29-38. doi: 10.4314/ejhs.v27i1.4s.
8
Survival analysis in the presence of competing risks.存在竞争风险时的生存分析。
Ann Transl Med. 2017 Feb;5(3):47. doi: 10.21037/atm.2016.08.62.
9
Introduction to the Analysis of Survival Data in the Presence of Competing Risks.存在竞争风险时生存数据的分析导论
Circulation. 2016 Feb 9;133(6):601-9. doi: 10.1161/CIRCULATIONAHA.115.017719.
10
The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study.埃塞俄比亚西北部贡德尔大学医院接受高效抗逆转录病毒治疗的艾滋病患者新发结核病对其免疫反应的影响:一项回顾性随访研究
BMC Infect Dis. 2014 Aug 27;14:468. doi: 10.1186/1471-2334-14-468.